VRelax for reducing stress
Recruiting
- Conditions
- Patients with burn-out, or a DSM-5 diagnosis of depressive disorder, bipolar disorder, anxiety disorder or psychotic disorder.
- Registration Number
- NL-OMON21150
- Lead Sponsor
- niversity Medical Center Groningen, Groningen, the Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
•Currently receiving ambulatory treatment for surmenage or burn-out, or DSM-5 depressive disorder, bipolar disorder, anxiety disorder or psychotic disorder.
•At least moderate level of perceived stress, based on self-report or clinician report
Exclusion Criteria
•DSM-5 diagnosis of substance use disorder
•Benzodiazepine use > 10 mg / day diazepam equivalent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The immediate effect on level of subjective stress, measured with Visual Analogue Scales (range 0-100) embedded in the VRelax and standard relaxation tools. Eight Ecological Momentary Assessment items are selected that have been used in previous studies.<br><br /><br /><br>2. VRelax user experiences are collected with interviews (previous experiences with relaxation exercises and VR, expectations met or not, ease and pleasure of using, quality, intensity, use of interactive elements), questionnaires (presence [IGroup Presence Questionnaire]), cyber sickness [Simulator Sickness Questionnaire SSQ]) and logging of use, including frequency, duration, time of day, type of environment visited.
- Secondary Outcome Measures
Name Time Method